Wencai Ye
Overview
Explore the profile of Wencai Ye including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
137
Citations
1245
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang Z, Huang W, Wang L, Li G, Xu F, Wu P, et al.
J Adv Res
. 2025 Jan;
PMID: 39864589
Introduction: Triple-negative breast cancer (TNBC) remains the most aggressive subtype of breast cancer, and effective therapeutic strategies are needed. Estrogen-related receptor alpha (ERRα) is considered a promising target for managing...
2.
Shi W, Wang R, Qian J, Wang L, Li Y, Mi Y, et al.
J Med Chem
. 2025 Jan;
68(2):1446-1472.
PMID: 39760276
Chemotherapy-induced myelosuppression (CIM) significantly impairs hematopoiesis. Trilaciclib (TC), originally developed for oncology application, is the only FDA-approved CDK4/6 inhibitor for CIM, which effectively protects bone marrow cells by inhibiting their...
3.
Shi X, Dai S, Song J, Zhang S, Zhang W, Guo Y, et al.
Bioorg Chem
. 2024 Dec;
154:108048.
PMID: 39662339
Meroterpenoids in the traditional Chinese medicine Arnebia euchroma are thought to be key components in its anti-inflammatory activity. In the present study, 17 meroterpenoids including four types of structural skeletons...
4.
Zou Q, Zhou X, Lai J, Zhou H, Su J, Zhang Z, et al.
Redox Biol
. 2024 Dec;
79():103460.
PMID: 39657365
Osteosarcoma (OS) is the most prevalent malignant bone tumor in children and adolescents worldwide. Identification of novel therapeutic targets and development of targeted drugs are one of the most feasible...
5.
Pan W, Miao Q, Yin W, Li X, Ye W, Zhang D, et al.
Cancer Drug Resist
. 2024 Dec;
7:43.
PMID: 39624083
Tumor-secreted exosomes are heterogeneous multi-signal messengers that support cancer growth and dissemination by mediating intercellular crosstalk and activating signaling pathways. Distinct from previous reviews, we focus intently on exosome-therapeutic resistance...
6.
Song J, Huang R, Cai J, Wu Z, Hu L, Sun W, et al.
Acta Pharm Sin B
. 2024 Nov;
14(10):4443-4460.
PMID: 39525571
The building blocks-based molecular network (BBMN) strategy was applied to the phytochemical investigation of , leading to the targeted isolation of eighteen novel cinnamoylphloroglucinol-terpene adducts (CPTAs) with diverse skeleton types...
7.
Song Q, Zhu H, Qiu M, Cai J, Hu Y, Yang H, et al.
mBio
. 2024 Aug;
15(9):e0138524.
PMID: 39162560
Importance: Respiratory syncytial virus (RSV) infection is a major public health concern, and many small-molecule candidates targeting the viral fusion (F) protein are associated with a considerable risk of inducing...
8.
Fan S, Qi M, Qi Q, Miao Q, Deng L, Pan J, et al.
Acta Pharm Sin B
. 2024 Feb;
14(2):682-697.
PMID: 38322324
Lymphatic metastasis is the main metastatic route for colorectal cancer, which increases the risk of cancer recurrence and distant metastasis. The properties of the lymph node metastatic colorectal cancer (LNM-CRC)...
9.
Ye W, Wang J, Little P, Zou J, Zheng Z, Lu J, et al.
Acta Pharm Sin B
. 2024 Jan;
14(1):1-19.
PMID: 38239238
No abstract available.
10.
Wang R, Hu X, Liu S, Wang J, Xiong F, Zhang X, et al.
Br J Pharmacol
. 2023 Nov;
181(8):1182-1202.
PMID: 37949672
Background And Purpose: Kaempferol-3-O-sophoroside (PCS-1) is the main component in Crocus sativus (Saffron), a herb with mood-enhancing properties. AMP-activated protein kinase (AMPK) is a potential therapeutic target for depression. This...